ATHA logo

ATHA

Athira Pharma Inc.

$0.39
-$0.01(-1.74%)
50
Overall
--
Value
50
Tech
--
Quality
Market Cap
$15.97M
Volume
56.01K
52W Range
$0.22 - $3.03
Target Price
$0.40
Order:

Income Statement

MetricTrendChart
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
OPERATING EXPENSES
Operating Expenses
$20.0M$64.0M$88.9M$127.1M$96.8M
Research & Development
$13.3M$42.8M$61.5M$93.8M$70.7M
Research Expense
$13.3M$42.8M$61.5M$93.8M$70.7M
Selling, General & Administrative
$6.7M$21.2M$32.6M$33.3M$26.1M
General & Administrative Expenses
$6.7M$21.2M$32.6M$33.3M$26.1M
Salaries & Wages
------$10.6M$11.0M
Depreciation & Amortization
$2.0K$479.0K$845.0K$969.0K$970.0K
Depreciation & Amortization
$2.0K$479.0K$845.0K$969.0K$970.0K
Other Operating Expenses
$85.0K$323.0K$-684.0K$-1.5M$-1.0M
OPERATING INCOME
Operating income
$-20.0M$-64.0M$-104.0M$-125.5M$-100.9M
EBITDA
$-19.6M$-54.7M$-88.0M$-116.5M$-95.7M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$367.0K$3.0K------
Intinc
$124.0K$337.0K------
Net Non-Operating Interest Income/Expense
$-243.0K$334.0K------
Other Income/Expense
$1.3M$-334.0K$-6.8M$-7.6M$-4.0M
Other Special Charges
$-1.3M$334.0K$3.2M$7.6M$4.0M
SPECIAL ITEMS
Restructring And Mn A Income
--------$2.9M
Special Income Charges
----$-10.0M$1.6M$-4.1M
PRE-TAX INCOME
EBIT
$-19.6M$-55.2M$-88.9M$-117.7M$-96.9M
Pre-Tax Income
$-21.3M$-63.7M$-95.6M$-117.8M$-96.9M
NET INCOME
Net Income
$-20.0M$-54.9M$-95.6M$-117.7M$-96.9M
Net Income (Continuing Operations)
$-20.0M$-54.9M$-95.6M$-117.7M$-96.9M
Net Income (Discontinued Operations)
$-20.0M$-54.9M$-95.6M$-117.7M$-96.9M
Net Income (Common Stockholders)
$-20.0M$-55.3M$-95.6M$-117.7M$-96.9M
Normalized Income
--------$-89.0M
TOTALS
Total Expenses
$20.0M$64.0M$88.9M$127.1M$96.8M
SHARE & EPS DATA
Average Shares Outstanding
$12.0M$36.9M$37.7M$38.0M$38.5M
Average Shares Outstanding (Diluted)
$12.0M$36.9M$37.7M$38.0M$38.5M
Shares Outstanding
$37.1M$37.6M$37.9M$38.3M$39.0M
Basic EPS
$-1.67$-1.49$-2.53$-3.09$-2.52
Basic EPS (Continuing Operations)
$-1.67$-1.49$-2.53$-3.09$-2.52
Diluted EPS
$-1.67$-1.49$-2.53$-3.09$-2.52
Diluted EPS (Continuing Operations)
----$-2.53$-3.09$-2.52
OTHER METRICS
Net Income From Other Gains Losses
$1.3M$8.8M$5.2M----
Non Recurring Operation Expense
----$10.0M$-1.6M$4.1M
Other Gand A
$6.7M$21.2M$32.6M$33.3M$26.1M
Restruct
--------$2.9M

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2ATHA$0.39-1.7%56.01K
3
4
5
6

Get Athira Pharma Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.